University of Texas, MD Anderson Cancer Center — Houston, Texas

University of Texas, MD Anderson Cancer Center is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Texas, MD Anderson Cancer Center has participated in 40 clinical trials with 13 currently active.

Therapeutic areas: Myelofibrosis, Indolent Systemic Mastocytosis, Smoldering Multiple Myeloma.

Sponsors: Telios Pharma, Inc., OncoPep, Inc., Acrivon Therapeutics.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas, MD Anderson Cancer Center?

University of Texas, MD Anderson Cancer Center has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas, MD Anderson Cancer Center conducted?

University of Texas, MD Anderson Cancer Center has 40 clinical trials on record, with 13 currently active. Their work covers Myelofibrosis, Indolent Systemic Mastocytosis, Smoldering Multiple Myeloma.

Is University of Texas, MD Anderson Cancer Center accredited by Crixeo Health?

Yes — University of Texas, MD Anderson Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Texas, MD Anderson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.